or Try an Advanced Search...

    Mesenchymal Stem Cell Stocks List

    Symbol Grade Name % Change
    ANIK A Anika Therapeutics Inc. 1.61
    BCLI D Brainstorm Cell Therapeutics Inc. 3.44
    BRTX D BioRestorative Therapies, Inc. -4.86
    LGVN F Longeveron Inc. -4.48
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Stem Cell Biology Biotechnology Adult Stem Cell Bone Bone Marrow Cell Biology Cell Therapy Life Sciences Therapeutic Products Acid Acute Respiratory Distress Syndrome Alzheimer’s Disease Amyotrophic Lateral Sclerosis Bone Grafting Burns Cataracts Cell Encapsulation Cell Product Degenerative Disease

    Related ETFs - A few ETFs which own one or more of the above listed Mesenchymal Stem Cell stocks.

    Symbol Grade Name Weight
    LABD B Direxion Daily S&P Biotech Bear 3X Shares 0.37
    SQLV C Legg Mason Small-Cap Quality Value ETF 0.26
    BTEC D Principal Healthcare Innovators Index ETF 0.11
    IWC C iShares Microcap ETF 0.1
    OMFS D Invesco Russell 2000 Dynamic Multifactor ETF 0.08
    View all Mesenchymal Stem Cell ETFs...
    Compare ETFs
    Compare BTEC to IWC Compare BTEC to OMFS Compare SQLV to OMFS

        Mesenchymal Stem Cell Stocks Recent News

        Date Stock Title
        Apr 18 LGVN Longeveron closes offering and raises $11.4M in proceeds
        Apr 18 LGVN Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
        Apr 18 ANIK Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
        Apr 18 LGVN Peering Into Longeveron's Recent Short Interest
        Apr 17 LGVN Longeveron announces exercise of warrants for $6.2M
        Apr 17 LGVN Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
        Apr 17 BCLI BrainStorm Cell Therapeutics promotes Bob Dagher to Chief Medical Officer
        Apr 16 BCLI BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
        Apr 16 BRTX BioRestorative gains as FDA clears amendment to study on cell therapy candidate
        Apr 16 LGVN LGVN Takes Steps Toward Success
        Apr 16 BRTX BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
        Apr 15 LGVN Longeveron stock rallies 85% on Alzheimer's presentation (update)
        Apr 15 LGVN Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
        Apr 15 LGVN Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
        Apr 14 BRTX 10 Micro-Cap Healthcare Stocks Insiders Are Buying
        Apr 13 LGVN Chief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)
        Related Industries: Biotechnology
        Related Stock Lists: Stem Cell Biology Biotechnology Adult Stem Cell Bone Bone Marrow Cell Biology Cell Therapy Life Sciences Therapeutic Products Acid Acute Respiratory Distress Syndrome Alzheimer’s Disease Amyotrophic Lateral Sclerosis Bone Grafting Burns Cataracts Cell Encapsulation Cell Product Degenerative Disease
        Mesenchymal Stem Cell

        Mesenchymal stem cells are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue).

        More about Mesenchymal Stem Cell
        Browse All Tags